Feng Xu, BS

Rain Oncology Inc.
Newark, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 24 - MILADEMETAN VS. TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: RESULTS FROM THE PHASE 3 MANTRA STUDY

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM